Multimodal analgesia in the treatment of a case of pediatric primary erythromelalgia with infection and pharma-ceutical care
- VernacularTitle:多模式镇痛治疗1例儿童原发性红斑性肢痛症伴感染并药学监护
- Author:
Mengqiu LI
1
;
Lei ZUO
2
;
Xin RAN
1
;
Qing LI
1
;
Xinyu LI
1
;
Ning LUO
1
Author Information
1. Dept. of Pharmacy，the First Affiliated Hospital of Chongqing Medical University，Chongqing 400016，China
2. Dept. of Pain Management，the First Affiliated Hospital of Chongqing Medical University，Chongqing 400016，China
- Publication Type:Journal Article
- Keywords:
erythromelalgia;
spinal cord electrical stimulation;
multimodal analgesia;
clinical pharmacist;
pharmaceutical care
- From:
China Pharmacy
2024;35(13):1658-1662
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To explore a multimodal analgesia regimen based on spinal cord electrical stimulation for children with primary erythromelalgia and the key points of pharmaceutical care. METHODS Clinical pharmacists participated in the treatment of a child with primary erythromelalgia complicated with skin infection. After reviewing domestic and foreign literature， multimodal analgesia was formulated and pharmaceutical care was carried out to address the difficulties in treating the patient’s illness. RESULTS The treatment team applied multimodal analgesia based on spinal cord electrical stimulation for the child， including a multi-drug combination involving different analgesic pharmacological targets， multiple administration routes （oral， intravenous， epidural， percutaneous）， multiple technologies （spinal cord electrical stimulation， local nerve block， patient- controlled analgesia）， individualized schemes of adjuvant therapy， and the child was monitored for the safety of drug use. The pain was controlled during the treatment and follow-up period， the wound was healed， and no serious adverse drug reactions occurred. CONCLUSIONS Multimodal analgesia based on spinal cord electrical stimulation is a safe and effective treatment for children with primary erythromelalgia.
